- Home
- TLRY vs ACHC Comparison
TLRY vs ACHC Comparison
Compare TLRY & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLRY | ACHC |
|---|---|---|
| Founded | N/A | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 919.2M | 1.1B |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TLRY | ACHC |
|---|---|---|
| Price | $6.76 | $27.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $72.33 | $22.27 |
| AVG Volume (30 Days) | ★ 5.9M | 2.4M |
| Earning Date | 04-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | $8.79 | $5.08 |
| Revenue Next Year | $19.98 | $5.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $0.36 | $11.43 |
| 52 Week High | $15.70 | $28.27 |
Technical Indicators
Market Signals| Indicator | TLRY | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 48.17 | 64.13 |
| Support Level | $6.13 | $23.02 |
| Resistance Level | $7.01 | $27.74 |
| Average True Range (ATR) | 0.54 | 1.09 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 13.26 | 77.12 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.